GSK Plc Form 6-K Summary
Business Context and Reporting Period
This Form 6-K, filed on May 14, 2024, serves as a transaction notification for GSK Plc. The filing discloses insider trading activities by Persons Discharging Managerial Responsibilities (PDMRs) and persons closely associated with them. The specific transactions reported occurred on May 10, 2024, on the London Stock Exchange.
Key Financial Metrics
The filing does not provide financial performance data such as revenue, profit, cash flow, margins, debt, or liquidity. It is strictly a regulatory disclosure of share acquisitions.
Material Changes and Transaction Details
The filing reports the acquisition of Ordinary Shares (ISIN: GB00BN7SWP63) by nine senior executives under the Company's Share Reward Plan. All transactions were executed at a price of £17.9434 per share. The volume for each executive was 14 Ordinary Shares, consisting of 7 partnership shares and 7 matching shares.
- Emma Walmsley (Chief Executive Officer): 14 shares acquired.
- Julie Brown (Chief Financial Officer): 14 shares acquired.
- James Ford (SVP and Group General Counsel): 14 shares acquired.
- Sally Jackson (SVP, Global Communications): 14 shares acquired.
- David Redfern (President Corporate Development): 14 shares acquired.
- Regis Simard (President, Global Supply Chain): 14 shares acquired.
- Philip Thomson (President, Global Affairs): 14 shares acquired.
- Deborah Waterhouse (CEO, ViiV Healthcare): 14 shares acquired.
- Victoria Whyte (Company Secretary): 14 shares acquired.
Guidance, Outlook, and Risks
The filing text does not provide management commentary, financial guidance, outlook, risks, contingencies, or unusual items. The document is limited to the statutory reporting of the specific share transactions listed above.
Investor Verification Points
- Verify the total number of shares acquired by PDMRs to ensure compliance with the Share Reward Plan limits.
- Confirm the transaction price of £17.9434 aligns with the market price on May 10, 2024.
- Note that this filing contains no operational or financial performance updates; refer to Form 20-F or quarterly reports for financial metrics.